Log in to search using one of your social media accounts:


Former GSK execs get $3.2M for research on a possible diabetes drug

A small Research Triangle Park company seeking to find next-generation drugs, received two federal grants totaling $3.2 million, an amount that will nearly triple the total the company has raised to date. NovaTarg – owned and led by former GlaxoSmithKline executives – will use the money to continue research on potential drug candidates for polycystic kidney disease and type 2 diabetes during this coming year. Diabetes is a potentially huge market, with some analysts estimating that even just…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

More News: Biotechnology | Diabetes | Diabetes Type 2 | Endocrinology | Grants | Health | Health Management | Polycystic Kidney Disease | Urology & Nephrology